cyclopentane has been researched along with rhodamine 123 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caceres, A; Feiguin, F; Ferreira, A; Kosik, KS | 1 |
Cui, C; Fu, L; Ge, C; Song, X; Su, X; To, KKW; Wang, F; Wang, X; Zhang, H | 1 |
2 other study(ies) available for cyclopentane and rhodamine 123
Article | Year |
---|---|
Kinesin-mediated organelle translocation revealed by specific cellular manipulations.
Topics: Actin Cytoskeleton; Animals; Base Sequence; Brefeldin A; Carbocyanines; Cells, Cultured; Cyclopentanes; Endocytosis; Fluorescent Dyes; Golgi Apparatus; Hippocampus; Kinesins; Microtubules; Mitochondria; Molecular Sequence Data; Neurites; Oligonucleotides, Antisense; Organelles; Protein Synthesis Inhibitors; Pyramidal Cells; Rhodamine 123; Rhodamines | 1994 |
PCI29732, a Bruton's Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells.
Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Cell Survival; Cyclopentanes; Doxorubicin; Drug Resistance, Neoplasm; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; Rhodamine 123 | 2018 |